W.R. Bezwoda - Concepedia

Author

W.R. Bezwoda

University of the Witwatersrand

Also Known As

W Bezwoda, W R Bezwoda, W. Bezwoda, W. R. BEZWODA, W. R. Bezwoda, W.R. Bezwoda, WR BEZWODA, WR Bezwoda

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of the Witwatersrand Johannesburg Hospital South African Institute for Medical Research

About

W.R. Bezwoda is an author at University of the Witwatersrand specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	19	863
2	Health Sciences	5	5	237
3	Cell Biology	3	3	140
4	Allergy	2	2	140
5	Applied Physiology	1	1	123

W.R. Bezwoda

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda, Journal of Clinical Oncology	1999	506
The non-immune inflammatory response: Serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein Roy Baynes, W.R. Bezwoda, T. H. Bothwell, Scandinavian Journal of Clinical and Laboratory Investigation Iron MetabolismImmunologyWhite Cell CountInflammationHematology	1986	130
Hematologic, iron-related, and acute-phase protein responses to sustained strenuous exercise C. B. Taylor, G. G. Rogers, Craig A. Goodman, Journal of Applied Physiology Physical ActivityIron MetabolismTransferrin SaturationKinesiologyBody Composition	1987	123
Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer Lesley Seymour, D. Dajee, W.R. Bezwoda Breast Cancer Research and Treatment Advanced Breast CancerBreast OncologyDerived-growth FactorMedicinePathology	1993	99
Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: Correlation with stage and rate of progression Samuel Ariad, L. Seymour, W.R. Bezwoda Breast Cancer Research and Treatment ThrombopoiesisBreast OncologyBlood PlateletPlatelet-derived Growth FactorBreast Cancer Patients	1991	98
Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer H. Kandl, Lesley Seymour, W.R. Bezwoda British Journal of Cancer Advanced Breast CancerBreast OncologySoluble C-erbb-2 FragmentMedicinePathology	1994	88
Randomised controlled trial of high dose chemotherapy (HD-CNVp) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer W.R. Bezwoda European Journal of Cancer Surgical OncologyBreast OncologyHealth SciencesMedicineCancer Management	1999	76
AN INVESTIGATION INTO GONADAL DYSFUNCTION IN PATIENTS WITH IDIOPATHIC HAEMOCHROMATOSIS W.R. Bezwoda, T. H. Bothwell, L. A. van der Walt, Clinical Endocrinology	1977	48
Lack of a significant independent effect of race on survival in breast cancer Roger Dansey, P. A. Hessel, S Browde, Cancer	1988	42
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer. J.-M. Nabholtz, B. Thuerlimann, W.R. Bezwoda, PubMed Breast OncologyDocetaxel Vs MitomycinMedicineSevere ThrombocytopeniaPharmacology	1997	34

Page 1